# Drusolv Therapeutics, Inc. — Form D

Drusolv Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-12. The offering totals $2.0M, of which $500K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-04-12
- Form: D
- Accession: 0001923102-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $500K
- Remaining: $1.5M
- Investors: 1
- Date of first sale: 2022-03-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-441520

## Issuer

- Name: Drusolv Therapeutics, Inc.
- CIK: 0001923102
- Entity type: Corporation
- Jurisdiction: PENNSYLVANIA
- Incorporated: 2017
- Address: 1425 LOCUST STREET, PHILADELPHIA, PA, 19102
- Phone: 404-536-4012

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| John G Edwards | Director | Philadelphia, PA |
| John G Edwards | Executive Officer | Philadelphia, PA |

## More

- [CIK 1923102 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1923102&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001923102-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.